These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4479728)

  • 1. Experimental endocrine exophthalmos: II. Effect of patients' sera on radiosulfate incorporation.
    Haddad HM; Loucas SP; Haddad H
    Ann Ophthalmol; 1974 Nov; 6(11):1201-3, 1205. PubMed ID: 4479728
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental endocrine exophthalmos: 1. Effect of TSH on S35 sulfate uptake.
    Haddad HM; Loucas SP; Haddad H
    Ann Ophthalmol; 1974 Jul; 6(7):721-5. PubMed ID: 4858446
    [No Abstract]   [Full Text] [Related]  

  • 3. [Frequency of the exophthalmos-producing factor (EPS) in clinical forms of exophthalmos].
    Stancu H; Dancăşiu M; Bălan M; Negoescu I
    Stud Cercet Endocrinol; 1969; 20(2):157-62. PubMed ID: 5394446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Total and free thyroxine in certain thyroid diseases (preliminary report)].
    Vurbanov V; Stancheva M; Strashimirov D
    Vutr Boles; 1974; 13(4):69-76. PubMed ID: 4141188
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the plasma thyrotropin in thyroid diseases].
    Lemarchand-Béraud T; Scazziga BR; Vannotti A
    Schweiz Med Wochenschr; 1966 Jun; 96(22):718-22. PubMed ID: 5988345
    [No Abstract]   [Full Text] [Related]  

  • 7. 35-S-sulfate uptake by mouse harderian gland: effect of serum from patients with Graves' disease.
    Singh SP; McKenzie JM
    Metabolism; 1971 Apr; 20(4):422-7. PubMed ID: 5107990
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of serum thrombomodulin(TM) levels in patients with hyper- or hypo- thyroidism].
    Soma M; Maeda Y; Matsuura R; Sasaki I; Kasakura S; Saeki Y; Ikekubo K; Ishihara T; Kurahachi H; Sasaki S; Tagami T; Nakao K
    Rinsho Byori; 1997 Jan; 45(1):77-81. PubMed ID: 9022347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine exophthalmos.
    Havard CW
    Br Med J; 1972 Feb; 1(5796):360-3. PubMed ID: 4550413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with radioimmunological TSH determination].
    Lauridsen UB; Deckert T; Friis T; Kirkegaard C; Hansen JM; Siersbaek-Nielsen K
    Ugeskr Laeger; 1974 Jun; 136(25):1365-8. PubMed ID: 4841109
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine exophthalmos].
    Lavergne G; Winand R
    Bull Soc Belge Ophtalmol; 1973; 163(1):1-170. PubMed ID: 4351085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Exophthalmogenic effect produced by endogenous and exogenous thyrotropic hormone in animal experiments. Studies with mercaptoimidazole, perchlorate and sera from hypothyroid patients without exophthalmos].
    Schemmel K; Weisbecker L; Kahl H; Uthgenannt H; Kreysing G; Zepf S
    Schweiz Med Wochenschr; 1972 May; 102(19):667-9. PubMed ID: 5063778
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the pathogenetic significance of hypophyseal factors in endocrine ophthalmopathy].
    Mertz DP; Stelzer M
    Dtsch Med Wochenschr; 1969 Jan; 94(1):27-32. PubMed ID: 5818126
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunochemiluminometric assay for measurement of thyrotropin in various thyroid disorders.
    Chailurkit L; Rajatanavin R
    J Med Assoc Thai; 1993 Sep; 76(9):501-5. PubMed ID: 7964256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood coagulation disorders in patients with thyroid glad dysfunction].
    Sheleg VA; Selivanova KF
    Probl Endokrinol (Mosk); 1967; 13(4):10-3. PubMed ID: 5633272
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease.
    Slyper AH; Shaker JL
    Clin Pediatr (Phila); 1993 Feb; 32(2):121-3. PubMed ID: 8094332
    [No Abstract]   [Full Text] [Related]  

  • 19. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.